Birchard, Dylan
Regeneron (United States)
2 papers on CoChatORCID 0009-0007-6493-1030
Most cited papers
- Verified
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
Le Floc’h, A., Allinne, J., Nagashima, K., Scott, G., Birchard, D., Asrat, S., Bai, Y., Lim, W. K., Martin, J., Huang, T., et al. (2020) · Allergy
Asthma and respiratory diseasesIL-33, ST2, and ILC Pathways
Cited by 545
- Verified
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
Orengo, J. M., Radin, A. R., Kamat, V., Badithe, A., Ben, L. H., Bennett, B. L., Zhong, S., Birchard, D., Limnander, A., Rafique, A., et al. (2018) · Nature Communications
Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research
Cited by 237
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free